LGC acquires Axolabs and invests in GMP manufacturing capacity for therapeutic nucleic acids

News (ZH) - Moves strengthen existing analytical and bioanalytical drug development service offering

2017-50-03
LGC invests in new GMP analytical capability

News (ZH) - The new labs comprise additional bioanalysis and synthetic chemistry labs as well as a new GMP CMC analytical capability for batch release testing of oligonucleotide-based drug substances

2018-00-01
LGC expands Fordham site to bolster Bioanalytical and CMC capacity

News (ZH) - LGC is expanding its Bioanalytical and CMC analytical services capacity at its site in Fordham, Cambridgeshire.

2017-00-23
LGC accelerates the development of new medicines with extractables and leachables services

News (ZH) - LGC is helping customers to identify and quantify the compounds present in those components in direct contact with a drug product or patient

2016-00-05
LGC completes first FDA inspection of its Sandwich laboratory

News (ZH) - This was the laboratory’s first inspection by the FDA and was an extensive audit focusing on GMP compliance.

2016-00-13
LGC launches new service for stability testing

News (ZH) - This new service enables continuous recording and monitoring of essential data on the impact of environmental factors, such as temperature and humidity, on the quality of a pharmaceutical product

2014-00-10
LGC launches cGMP cell-based assay capability

News (ZH) - The cGMP service is an extension to the existing cell-based assay capability that LGC’s experienced team offer for biopharmaceutical development

2014-00-20
LGC welcomes HRH The Princess Royal

News (ZH) - The Princess Royal was given a tour of LGC’s recently-expanded laboratories and met with scientists and apprentices to hear how the company’s cutting-edge analytical science supports doping and medication control in animal sports, provides assurance to athletes taking supplements, and helps develop new drugs and therapies

2019-38-01